_            _    _        _         _
      /\ \         /\ \ /\ \     /\_\      / /\
      \_\ \       /  \ \\ \ \   / / /     / /  \
      /\__ \     / /\ \ \\ \ \_/ / /     / / /\ \__
     / /_ \ \   / / /\ \ \\ \___/ /     / / /\ \___\
    / / /\ \ \ / / /  \ \_\\ \ \_/      \ \ \ \/___/
   / / /  \/_// / /   / / / \ \ \        \ \ \
  / / /      / / /   / / /   \ \ \   _    \ \ \
 / / /      / / /___/ / /     \ \ \ /_/\__/ / /
/_/ /      / / /____\/ /       \ \_\\ \/___/ /
\_\/       \/_________/         \/_/ \_____\/
r-escalation 0.2.3
Propagated dependencies: r-viridis@0.6.5 r-trialr@0.1.6 r-tidyselect@1.2.1 r-tidyr@1.3.2 r-tibble@3.3.1 r-testthat@3.3.2 r-stringr@1.6.0 r-rcolorbrewer@1.1-3 r-r6@2.6.1 r-purrr@1.2.2 r-mvtnorm@1.4-1 r-magrittr@2.0.5 r-iso@0.0-21 r-gtools@3.9.5 r-ggplot2@4.0.3 r-dplyr@1.2.1 r-diagrammer@1.0.12 r-dfcrm@0.2-2.1 r-boin@2.7.2 r-binom@1.1-1.1
Channel: guix-cran
Location: guix-cran/packages/e.scm (guix-cran packages e)
Home page: https://brockk.github.io/escalation/
Licenses: GPL 3+
Build system: r
Synopsis: Modular Approach to Dose-Finding Clinical Trials
Description:

This package provides methods for working with dose-finding clinical trials. We provide implementations of many dose-finding clinical trial designs, including the continual reassessment method (CRM) by O'Quigley et al. (1990) <doi:10.2307/2531628>, the toxicity probability interval (TPI) design by Ji et al. (2007) <doi:10.1177/1740774507079442>, the modified TPI (mTPI) design by Ji et al. (2010) <doi:10.1177/1740774510382799>, the Bayesian optimal interval design (BOIN) by Liu & Yuan (2015) <doi:10.1111/rssc.12089>, EffTox by Thall & Cook (2004) <doi:10.1111/j.0006-341X.2004.00218.x>; the design of Wages & Tait (2015) <doi:10.1080/10543406.2014.920873>, and the 3+3 described by Korn et al. (1994) <doi:10.1002/sim.4780131802>. All designs are implemented with a common interface. We also offer optional additional classes to tailor the behaviour of all designs, including avoiding skipping doses, stopping after n patients have been treated at the recommended dose, stopping when a toxicity condition is met, or demanding that n patients are treated before stopping is allowed. By daisy-chaining together these classes using the pipe operator from magrittr', it is simple to tailor the behaviour of a dose-finding design so it behaves how the trialist wants. Having provided a flexible interface for specifying designs, we then provide functions to run simulations and calculate dose-paths for future cohorts of patients.

Total packages: 1